Qu Biologics' Unattributed Round

Qu Biologics raised a round of funding on April 13, 2016.

Qu Biologics develops Site Specific Immunomodulators (SSI), a novel class of immunotherapies that aim to restore the body's normal immune response. SSIs are designed to stimulate an immune response in…

Articles about Qu Biologics' Unattributed Round: